2007
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas
Terry MB, Gammon MD, Zhang FF, Vaughan TL, Chow WH, Risch HA, Schoenberg JB, Mayne ST, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF, Santella RM. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Cancer Causes & Control 2007, 18: 1039-1046. PMID: 17665311, DOI: 10.1007/s10552-007-9046-0.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAdultAgedAlcohol DehydrogenaseAlcohol DrinkingAllelesCase-Control StudiesChi-Square DistributionConfidence IntervalsEsophageal NeoplasmsFemaleGene FrequencyGenotypeHomozygoteHumansInterviews as TopicLogistic ModelsMaleMiddle AgedOdds RatioPolymorphism, GeneticRisk FactorsStomach NeoplasmsUnited StatesConceptsRisk of esophagealEsophageal adenocarcinomaHigh riskGastric Cancer StudyGastric cardia adenocarcinomaGastric adenocarcinomaCarcinoma riskConclusionThese dataCancer riskCardia adenocarcinomaTumor typesAdenocarcinomaAlcohol dehydrogenase 3Common polymorphismsEsophagealRisk estimatesCancer studiesRiskAlcohol dehydrogenase 3 geneDrinkersDehydrogenase 3PolymorphismNondrinkersMethodsWeGenotypes
2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL, Rosoff L, Garcia‐Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, West AB, Wheeler DE, Contos MJ, Hofmann AF. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology 2005, 42: 1184-1193. PMID: 16250039, DOI: 10.1002/hep.20897.Peer-Reviewed Original ResearchConceptsPrimary biliary cirrhosisUrsodeoxycholic acidVariceal bleedingBiliary cirrhosisTreatment failureSerum bilirubinHistological stagingCourse of PBCM2 body surface areaData Safety Monitoring BoardAMA-positive patientsReasons of futilityFailure of treatmentDevelopment of ascitesBody surface areaSafety monitoring boardEffect of methotrexateLiver transplantationPositive patientsMulticenter trialMedian periodMedian timeHistological progressionMonitoring boardDrug toxicity
2004
”Fractured Colon”
Sherman A, Ackert JJ, Rajapaksa R, West AB, Oweity T. ”Fractured Colon”. Journal Of Clinical Gastroenterology 2004, 38: 341-345. PMID: 15087693, DOI: 10.1097/00004836-200404000-00008.Peer-Reviewed Original ResearchConceptsCollagenous colitisTissue specimensChronic nonbloody diarrheaLinear mucosal tearsFree intraperitoneal airPatient tissue specimensFibrotic submucosaNonbloody diarrheaAcute peritonitisColonic perforationClinical courseIntraperitoneal airMucosal tearsPlain radiographsResection specimenDiagnostic colonoscopyLinear ulcerSubmucosal fibrosisColonic mucosaCollagen depositionSurface epitheliumAir dissectionAir insufflationColitisVariable severity
2003
Stellate-Cell Lipidosis in Liver Biopsy Specimens
Levine PH, Delgado Y, Theise ND, West AB. Stellate-Cell Lipidosis in Liver Biopsy Specimens. American Journal Of Clinical Pathology 2003, 119: 254-258. PMID: 12579996, DOI: 10.1309/6dkc03c4gaaen2dk.Peer-Reviewed Original ResearchConceptsLiver biopsy specimensHypervitaminosis ABiopsy specimensAbnormal liver enzyme levelsOral vitamin ALiver enzyme levelsLipid-laden cellsCrescent-shaped nucleusMethotrexate useHepatitis CLiver biopsyLiver injuryMedication useTopical tretinoinSpace of DisseInconspicuous nucleoliPreventable formAlcohol abuseDiagnostic criteriaVitamin ALipidosisSynthetic retinoidsPatient detailsBiopsyPatients